ThermoGenesis Holdings Inc

-0.23 (-21.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.57M
Current PEN/A
Forward PE N/A
2yr Forward PE 10.25
See more stats
Estimates Current Quarter
Revenue$3.6 Million
Adjusted EPS-$0.01
See more estimates
10-Day MA$0.93
50-Day MA$0.63
200-Day MA$1.08
See more pivots

ThermoGenesis Holdings Inc Stock, NASDAQ:THMO

2711 Citrus Road, Rancho Cordova, California 95742
United States of America
Phone: +1.916.858.5100
Number of Employees: 41


ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.